Acura Pharma (ACUR) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Price: $0.00 --0%
Financial Fact:
Income (loss) from operations: -2.07M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income (loss) from operations: -2.07M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Acura Pharma (NASDAQ: ACUR) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $218 thousand versus the consensus estimate of $230 thousand.
For earnings history and earnings-related data on Acura Pharma (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
